Diploma (DPLM) Stock Rating Reaffirmed by Peel Hunt

Share on StockTwits

Diploma (LON:DPLM)‘s stock had its “add” rating reissued by investment analysts at Peel Hunt in a note issued to investors on Friday.

A number of other equities analysts also recently issued reports on DPLM. Jefferies Financial Group cut their price target on shares of Diploma from GBX 1,350 ($17.64) to GBX 1,320 ($17.25) and set a “buy” rating for the company in a report on Monday, August 6th. Numis Securities downgraded shares of Diploma to a “hold” rating and set a GBX 1,275 ($16.66) price target for the company. in a report on Wednesday, August 22nd. Finally, Berenberg Bank reiterated a “buy” rating and issued a GBX 1,365 ($17.84) price target on shares of Diploma in a report on Thursday, September 6th. Three analysts have rated the stock with a hold rating and two have issued a buy rating to the company. Diploma currently has an average rating of “Hold” and an average price target of GBX 1,342 ($17.54).

Shares of DPLM opened at GBX 1,260 ($16.46) on Friday. Diploma has a 52-week low of GBX 1,010 ($13.20) and a 52-week high of GBX 1,270 ($16.59).

About Diploma

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in North America, Europe, and internationally. It operates through Life Sciences, Seals, and Controls business sectors. The Life Sciences sector supplies consumables and instruments for the diagnostic testing of blood, tissue, and other samples in hospital pathology laboratories; electrosurgery equipment and consumables for use in hospital operating rooms; and surgical medical devices, and related consumables and services to GI endoscopy suites in hospitals and private clinics.

Further Reading: Market Capitalization, Large-Caps, Mid-Caps, Small-Caps

Analyst Recommendations for Diploma (LON:DPLM)

Receive News & Ratings for Diploma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diploma and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply